NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced that on June 3, 2025, it received notice from the Nasdaq Hearings Panel confirming compliance with the minimum bid price requirement under Listing Rule 5550(a)(2).
The Panel also reminded the Company to meet the equity requirement in Listing Rule 5550(b)(1) by June 30, 2025, as per the granted extension. The Nasdaq Listing Qualifications process will remain open until the Company meets all continued listing requirements.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.